Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone Dosing for Hidradenitis Suppurativa
NCT04582669Phase 4Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Jan 2022
- Primary completion
- Oct 2022
- Countries
- 1
01
Overview
A Phase 4 trial of triamcinolone in hidradenitis suppurativa (HS), sponsored by Montefiore Medical Center. Started Jan 2022; status: terminated.
02
Drugs
triamcinolone
03
Conditions
hidradenitis suppurativa (HS)
Beyond the preview
Go deeper on NCT04582669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04582669.